23 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Sales 3rd quarter 2023: 136M€ The Vetoquinol Group posted sales of €136 million in Q3 2023, up +1.3% on a reported basis and +5.1% at constant exchange rates. Over the same period, Vetoquinol recorded a negative currency impact of -€5 million, linked to the Americas and Asia Pacific/Rest of World territories. |
26/10/2023 | Public releases | |
Sustainable development, an integral part of Vetoquinol Vetoquinol's corporate vision underlines its ambition for its entire ecosystem. This vision creates a dynamic for sustainable development by stating that by 2033 the company will be "the most agile animal health laboratory where employees, experts, partners, and customers work together to create customized solutions dedicated to animal health for a better planet". |
13/09/2023 | Press releases communication | |
Rapport financier semestriel 2023 (french) Rapport financier semestriel 2023 (french) |
12/09/2023 | Half Year Report | |
2023 HALF-YEAR RESULTS Sales: €256m (-5.4% as reported) |
07/09/2023 | Public releases | |
2023 Half-Year Results Contents |
07/09/2023 | Half Year Report | |
Mastaplex and Vetoquinol announce distribution agreement Mastaplex Ltd (New Zealand, unlisted) and Vetoquinol (VETO: France Euronext) are pleased to announce an extension of their exclusive distribution agreement for Mastatest.. |
27/07/2023 | Press releases communication | |
Rapport financier semestriel 2022 (french) Rapport financier semestriel 2022 (french) |
26/06/2023 | Half Year Report | |
Growth driven by innovation Ever since the company was founded in 1933, innovation has been a major component of Vetoquinol's development strategy. |
13/06/2023 | Press releases communication | |
Rémunération et politique des dirigeants - mai 2023 (french) Rémunération et politique des dirigeants |
07/06/2023 | Shareholders´s Meeting | |
Vetoquinol - assemblée générale mixte - 25 mai 2023 : résultat du scrutin |
26/05/2023 | Shareholders´s Meeting |